Drugs and FDA
FDA approves GSK and Ionis hepatitis B drug Hibsago
For eligible adults without cirrhosis, Hibsago is used with existing antivirals. 19% of trial patients maintained viral control 24 weeks after stopping all hepatitis B treatment.
Drug facts and side effects, recalls, research, clinical trials and medical reference in one search.
More top stories
Research
Psilocybin linked to lower inflammation markers in small Parkinson’s study
A small, uncontrolled Parkinson’s study found lower inflammation markers after psilocybin, but the findings need confirmation in a randomized trial.
Vaccines
Guinea-Bissau hepatitis B newborn vaccine trial halted
The lead researcher said the trial will not proceed because it lacked necessary government approval.
Health policy
Trump administration launches national kidney care plan
The plan sets priorities for preventing kidney failure, improving dialysis care and reforming the transplant system.
Health policy
England proposes restricting high-risk cosmetic procedures to qualified clinicians
The proposals would restrict liquid Brazilian butt lifts to doctors and other high-risk procedures to specified, qualified healthcare professionals.
Drugs and FDA
Roivant reports brepocitinib success in two uveitis trials
BioPharma Dive also reported positive results for the inflammatory eye condition, describing them as another win for the drug after its first approval for dermatomyositis.
Hospitals
Hackensack Meridian agrees to acquire Hunterdon Health and invest about $230 million
Hackensack Meridian plans to invest about $230 million in Hunterdon if regulators approve the acquisition.
Insurance
Centene and Oscar outline 2027 ACA marketplace plans
Oscar plans to add 140 counties, while Centene’s county additions do not change its overall footprint after it exits Delaware and New Hampshire.
Research
Retatrutide improved sleep apnea in two trials of adults with obesity
At 80 weeks, retatrutide reduced apnea-hypopnea index more than placebo in adults with obesity, including those with type 2 diabetes.
Research
Rapport’s RAP-219 meets main goal in Phase 2 bipolar mania study
Rapport said RAP-219 improved mania symptoms more than placebo over three weeks, with a statistically significant difference on the study’s main measure.
Industry
American Diabetes Association announces Rita Kalyani’s departure
The ADA said Rita Kalyani is no longer its chief scientific and medical officer, effective immediately.
Safety alerts
Recalls to know about
-
Quad-Mix and Tirzepatide/Cyanocobalamin and 5 more (16 products)
Carolina Infusion recalled injectable Quad-Mix, tirzepatide/cyanocobalamin 26/2 mg/mL, and Tri-Mix 30/1/20 and 30/1/10 syringes because sterility cannot be guaranteed.
-
Tirzepatide Injection and Apothecary Nad+ Injection (2 products)
Tirzepatide 18mg/mL, 4 mL and NAD+ 200 mg/mL, 6 mL multi-dose vials were recalled because sterility cannot be guaranteed.
-
Houston Rx recalled tirzepatide/niacinamide 20mg/2mg/mL injection in a 2mL vial (40 MG per Vial) because it cannot be guaranteed sterile.
-
Cyanocobalamin and Trace Elements Injection 4 and 7 more (12 products)
American Regent recalled cyanocobalamin 10,000 mcg/10 mL injection, Multrys 1 mL vials, acetylcysteine 20% 4 mL vials and papaverine 60 mg/2 mL injection vials because...
Current drug shortages
-
Oncology
Oct. 20
-
Oncology
Oct. 20
-
Methylphenidate Hydrochloride Tablet, Extended Release
Psychiatry
Oct. 20
-
Gastroenterology
Oct. 19
-
Bupivacaine Hydrochloride Injection
Anesthesia
Oct. 19
Guidelines quick reference
-
Hypertension: diagnosis & target
ACC/AHA 2025 · USPSTF 2021 · AAFP 2022
-
Statins for primary prevention
USPSTF 2022 · ACC/AHA 2026 · VA/DoD 2025
-
Type 2 diabetes: screening & A1c target
USPSTF 2021 · ADA 2026
-
Atrial fibrillation: stroke prevention and anticoagulation
ACC/AHA/ACCP/HRS 2023 · USPSTF 2022
-
USPSTF 2021 · ACS 2026 · Multi-Society Task Force (ACG/AGA/ASGE) 2022 · ACP 2023
-
USPSTF 2024 · ACS 2015 · ACOG 2024 · ACP 2026
-
CDC / ACIP 2025 · AAFP 2026 · ACP 2026
-
Uncomplicated UTI (cystitis) in women
IDSA 2025 · AUA/CUA/SUFU 2025 · USPSTF 2019
History of medicine
